Skip to content

AptarGroup ATR Derivative assets

Derivative assets at other companies

Merck & Co. logo
Merck & Co.MRK
$562M+37.1%
Amcor logo
AmcorAMCR
Baxter International logo
Baxter InternationalBAX
Halozyme Therapeutics logo
Halozyme TherapeuticsHALO
DuPont de Nemours, Inc. logo
DuPont de Nemours, Inc.DD

Other financials

Income statement

See full
Revenue$982.9M+10.8%
Gross profit$351.9M+4.6%
Operating income$107.5M-5.2%
Net income$72.7M-7.8%
EPS (diluted)$1.12-4.3%

Balance sheet

See full
Cash & equivalents$225.0M+78.8%
Total debt$1.4B+32.7%
Total equity$2.6B+3.6%
Total assets$5.1B+12.6%

Cash flow

See full
Operating cash flow$118.7M+43.5%
CapEx$65.4M+15.0%
Free cash flow$53.3M+106%

Valuation

See full
Market cap$7.68B-17.9%
Enterprise value$8.89B-13.9%
P/E19.9×-5.4×
P/S-0.6×

Profitability

See full
Gross margin36.7%-1.6pp
Operating margin12.8%-1.2pp
Net margin10%-0.4pp
FCF margin8.4%-2.1pp

Returns & leverage

See full
Return on equity15%-0.2pp
Debt / equity0.5×+0.1×
Current ratio1.7×+0.4×

Where this comes from

Reported directly by AptarGroup in its filing.

Tagged under the XBRL concept us-gaap:DerivativeAssets.

The official record: AptarGroup’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →

Ask your AI about AptarGroup's derivative assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is AptarGroup's derivative assets?
AptarGroup (ATR) reported derivative assets of $778K in Q1 2026.
How has AptarGroup's derivative assets changed year-over-year?
AptarGroup's derivative assets increased by 20.8% year-over-year, from $644K to $778K.
What is the long-term trend for AptarGroup's derivative assets?
Over 5 years (2020 to 2025), AptarGroup's derivative assets has grown at a -1.5% compound annual growth rate (CAGR), from $322K to $298K.